Drug development

#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Drug Discovery Innovators and Investors (DDII) conference: Event summary

The second event in the Drug Discovery Innovators and Investors (DDII) event series took place on 4 November, 2026, bringing together representatives from across the UK life sciences sector to discuss the opportunities and challenges facing drug discovery and development. Held in London under the theme Technology, Scale, and Capital:… Read More

#News

London skyline
#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Next week: DDW’s Drug Discovery Innovators and Investors (DDII) conference

DDW’s Drug Discovery Innovators and Investors (DDII) conference returns to London on 4 November, bringing together leaders from pharma and biotech, technology suppliers, academia, start-ups, spin-outs and the investment community. Date: Wednesday, 4 November 2026 Time: 09:00–17:00 Venue: etc.venues Monument, 8 Eastcheap, London, EC3M 1AE The one-day conference will explore… Read More

#News

GPCRs
#Drug activity #Drug development #Drug discovery #GPCR

Last chance to register: Improving the predictive power of GPCR assays

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug development #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (19-23 October)

News round-up for 19-23 October 2026 by Megan Thomas, Multimedia Editor at DDW.  In this week’s news roundup, drug discovery and biopharma companies continue to make progress across the drug development pipeline, with recent updates highlighting clinical trial milestones, emerging research and investment in new treatments. The… Read More

#News

#Drug activity #Drug development #Drug discovery #GPCR

Webinar: Revealing hidden pharmacology with GPCR assays

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Summit: What advances are driving immuno-oncology drug discovery?

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More

#News

Immunotherapy
#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Register now for immuno-oncology summit

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More

#News

Basel map
#Academic #Biotech #Drug development #Drug discovery #Life sciences

How the right environment accelerates biotech innovation

Christof Klöpper, CEO of Basel Area Business and Innovation, discusses how ecoystems for biotech can advance innovation and how the Basel area is an example of an impressive concentration of talent.  A decade ago, the typical formula for biotech locations went something like this: emerge from an academic institution or… Read More

#Exclusive Content

#Drug activity #Drug development #Drug discovery #GPCR

Register now: Improving the predictive power of GPCR assays

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

#Contract Research Organisations (CROs) #Drug development #Drug discovery #High throughput screening #Small molecules

Advancing small molecule drug discovery

DDW Editor Reece Armstrong speaks to Dr. Zachary Gurard-Levin, CEO and Founder of Peapod Bio about challenges in small molecule drug discovery and what technologies are advancing this sector.    RA: What are the biggest challenges facing small molecule drug discovery and development?  ZG: The challenge that we… Read More

#Exclusive Content

Brain physiology
#Drug development #Drug discovery #Neuroscience #Sleep disorders #Small molecules

Why sleep is the next frontier in brain health 

Michelle L. Mellion, MD, Chief Medical Officer at AstronauTx discusses why small molecules that can restore deep, restorative sleep, could be key to cognitive diseases such as Alzheimer’s.   Sleep is the bedrock of good brain health. For a long time, the focus has been on the quantity of sleep. A large body of evidence has… Read More

#Exclusive Content

#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Summit explores advances driving immuno-oncology drug discovery

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More

#News

#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Full agenda announced for DDW’s London, UK Conference

DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development. This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar – Advances in cell and gene therapy

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Drug activity #Drug development #Drug discovery #GPCR

Webinar explores true drug activity through functional volume control

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy

Advances and challenges in cell and gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne, this webinar explores the advances and challenges taking place within the cell and gene therapy field. Hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo Therapeutics. Throughout the… Read More

Webinar date:
Sponsored by Bio-Techne
#Featured Webinars